GlassScriptPhysician profile
Reid H Wilson
NPI 1699948588
$9,346.19
in general payments reported to CMS, 2019-2025
26 companies · $2,876 in 2025
The $2,876 reported for 2025 was more than what 75% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $481 · 2020: $101 · 2021: $521 · 2022: $4,474 · 2023: $360 · 2024: $533 · 2025: $2,876.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,891 · Travel and Lodging: $1,871 · Long Term Medical Supply Or Device Loan: $7.45.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,890.94 |
| Travel and Lodging | $1,870.88 |
| Long Term Medical Supply Or Device Loan | $7.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $4,748.42 | 2019-2025 | Journey II, Ri Hip Navigation, Real Intelligence |
| Crossroads Orthopedics, LLC | $1,247.98 | 2022-2023 | |
| Arthrex, INC. | $801.24 | 2022-2025 | |
| Stryker Corporation | $797.63 | 2020-2025 | Alphavent, Triathlon, Accolade |
| Zimmer Biomet Holdings, INC. | $697.53 | 2019-2025 | Persona, Ventix, Juggerknotless Soft Anchor |
| Mf Med | $153.85 | 2025 | |
| Si-Bone, INC. | $120.99 | 2021-2022 | |
| Radius Health, INC. | $96.02 | 2021-2025 | Tymlos |
| Amgen INC. | $92.14 | 2019-2023 | |
| Ferring Pharmaceuticals INC. | $85.84 | 2021-2025 | Euflexxa |
| Depuy Synthes Sales INC. | $77.37 | 2019-2025 | Dynacord |
| Polynovo North America LLC | $73.12 | 2023 | |
| Vertex Pharmaceuticals Incorporated | $55.81 | 2024-2025 | |
| Avanos Medical | $48.59 | 2019-2024 | Coolief* Cooled Radiofrequency |
| Pacira Therapeutics, INC. | $43.76 | 2020 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Pharmaceuticals Incorporated | $42.63 | 2021-2024 | Exparel, Zilretta |
| Nevro Corp. | $34.36 | 2023 | Senza |
| Vericel Corporation | $20.93 | 2025 | Maci |
| Heron Therapeutics, INC. | $20.00 | 2021 | |
| Endo Pharmaceuticals INC. | $15.16 | 2019 | |
| Bioventus LLC | $14.04 | 2024 | Exogen Ultrasound Bone Healing System |
| Dynasplint Systems INC. | $13.23 | 2019 | |
| Kci USA, INC. | $13.02 | 2023 | V.A.C. Veraflo, Prevena |
| Sanofi-Aventis U.S. LLC | $11.56 | 2019 | |
| Acacia Pharma INC | $11.24 | 2021 | |
| Orthofix Medical, INC. | $9.73 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Reid Wilson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.